Wim H. Scheele

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Jean‐Jacques Body, Gregory Gaich, Wim H. Scheele et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 365 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis

Robert Lindsay, Wim H. Scheele, Robert M. Neer et al. · Archives of Internal Medicine · 2004 · 328 citations

Medicine, Orthopedic Surgery, Pharmacotherapy +17

Additive Effects of Raloxifene and Alendronate on Bone Density and Biochemical Markers of Bone Remodeling in Postmenopausal Women with Osteoporosis

Olof Johnell, Wim H. Scheele, Yili Lu et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 225 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy

Wim H. Scheele, Susan M. Diamond, Jeremy D. Gale et al. · Journal of the American Society of Nephrology · 2016 · 65 citations · Full text

Medicine, Nephrology, Pharmacology +16

Efficacy and Safety of Recombinant Human Bone Morphogenetic Protein-2/Calcium Phosphate Matrix for Closed Tibial Diaphyseal Fracture

Thomas R. Lyon, Wim H. Scheele, Mohit Bhandari et al. · Journal of Bone and Joint Surgery · 2013 · 58 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17